amobarbital has been researched along with Sarcoma in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
JUHASZ, J | 1 |
BALO, J | 1 |
KENDREY, G | 1 |
Mordarski, M | 1 |
Chylińska, B | 1 |
Urbański, T | 1 |
2 other studies available for amobarbital and Sarcoma
Article | Year |
---|---|
[New experimental strain of tumor; amytal ascites sarcoma].
Topics: Amobarbital; Animals; Ascites; Barbiturates; Neoplasms; Sarcoma; Sarcoma, Experimental | 1955 |
Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
Topics: Amobarbital; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Lymphoma; Mice; Neoplasms, Ex | 1970 |